CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Xsensio has developed the CytoTrack platform, a wearable system that continuously and non-invasively monitors health parameters, particularly inflammatory markers in patients. This technology aims to enhance personalized medicine by providing real-time health insights, especially for those at risk of severe conditions…
Xsensio is an innovation-driven Swiss company dedicated to solving one of the biggest challenges for personalized medicine: the lack of real-time, continuous monitoring of health parameters in patients.
Xsensio has built the highly modular CytoTrack breakthrough sensing platform to continuously and non-invasively track biochemical information as a wearable system and offer critical health insight in real time.
CytoTrack has potential to continuously monitor inflammatory markers that tend to sudd…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
